Zobrazeno 1 - 10
of 726
pro vyhledávání: '"Gonzalez De Castro D"'
Autor:
Khouja M; Second Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany., Jiang L; Institute for Medical Information Processing, Biometry and Epidemiology (IBE), Faculty of Medicine, LMU Munich, Munich, Germany., Pal K; Second Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany.; Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Stewart PJ; The Patrick G Johnston Centre for Cancer Research, Queens University Belfast, Belfast, UK., Regmi B; Second Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany.; Department of Pneumology and Intensive Care Medicine, University Hospital RWTH Aachen, Aachen, Germany., Schwarz M; Second Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany., Klapper W; Department of Pathology, Hematopathology Section and Lymph Node Registry, University Hospital Schleswig-Holstein, Kiel, Germany., Alig SK; Department of Medicine III, University Hospital, Ludwig-Maximilian-University, Munich, Germany., Darzentas N; Second Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany., Kluin-Nelemans HC; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Hermine O; Department of Hematology, Hôpital Necker, Assistance Publique Hôpitaux de Paris, University Paris Descartes, Paris, France.; INSERM U1163 and CNRS 8254, Imagine Institute, Université Sorbonne Paris Cité, Paris, France., Dreyling M; Department of Medicine III, University Hospital, Ludwig-Maximilian-University, Munich, Germany., Gonzalez de Castro D; The Patrick G Johnston Centre for Cancer Research, Queens University Belfast, Belfast, UK., Hoster E; Institute for Medical Information Processing, Biometry and Epidemiology (IBE), Faculty of Medicine, LMU Munich, Munich, Germany., Pott C; Second Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany. c.pott@med2.uni-kiel.de.
Publikováno v:
Leukemia [Leukemia] 2024 Sep 16. Date of Electronic Publication: 2024 Sep 16.
Autor:
Moorcraft, S.Y., Gonzalez de Castro, D., Cunningham, D., Jones, T., Walker, B.A., Peckitt, C., Yuan, L.C., Frampton, M., Begum, R., Eltahir, Z., Wotherspoon, A., Teixeira Mendes, L.S., Hulkki Wilson, S., Gillbanks, A., Baratelli, C., Fotiadis, N., Patel, A., Braconi, C., Valeri, N., Gerlinger, M., Rao, S., Watkins, D., Chau, I., Starling, N. *
Publikováno v:
In Annals of Oncology January 2018 29(1):230-236
Autor:
Larkin J; Skin and Renal Units, The Royal Marsden Hospital NHS Foundation Trust, London, UK; Melanoma and Kidney Cancer Team, The Institute of Cancer Research, London, UK., Marais R; Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK., Porta N; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK., Gonzalez de Castro D; Molecular Diagnostics, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK., Parsons L; University of Edinburgh, Edinburgh, UK; PDD - Thermo Fisher Scientific, Bend, Oregon, USA., Messiou C; Department of Radiology, The Royal Marsden Hospital NHS Foundation Trust, London, UK., Stamp G; Department of Histopathology, The Royal Marsden Hospital NHS Foundation Trust, London, UK., Thompson L; Centre for Molecular Pathology, The Royal Marsden Hospital NHS Foundation Trust, London, UK., Edmonds K; Skin and Renal Units, The Royal Marsden Hospital NHS Foundation Trust, London, UK., Sarker S; Skin and Renal Units, The Royal Marsden Hospital NHS Foundation Trust, London, UK., Banerji J; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK., Lorigan P; Division of Cancer Sciences, Unviersity of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK., Evans TRJ; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Corrie P; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Marshall E; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK., Middleton MR; Department of Oncology, University of Oxford, Oxford, UK., Nathan P; Mount Vernon Cancer Centre, East & North Herts NHS Trust, Northwood, UK., Nicholson S; University Hospitals of Leicester NHS Foundation Trust, Leicester, UK., Ottensmeier C; University Hospitals Southampton NHS Foundation Trust, Southampton, UK., Plummer R; Newcastle University and Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK., Bliss J; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK., Valpione S; Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK. Electronic address: sara.valpione@cruk.manchester.ac.uk., Turajlic S; Skin and Renal Units, The Royal Marsden Hospital NHS Foundation Trust, London, UK; Melanoma and Kidney Cancer Team, The Institute of Cancer Research, London, UK; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK. Electronic address: samra.turajlic@crick.ac.uk.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2024 Mar 19; Vol. 5 (3), pp. 101435. Date of Electronic Publication: 2024 Feb 27.
Autor:
van den Brand M; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., Möbs M; Institute of Pathology, Charité-Universitätsmedizin, Berlin, Germany., Otto F; Institute of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany., Kroeze LI; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands; Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Gonzalez de Castro D; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, United Kingdom., Stamatopoulos K; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece., Davi F; Hematology Department, Hospital Pitié-Salpêtrière, Sorbonne University, Paris, France., Bravetti C; Hematology Department, Hospital Pitié-Salpêtrière, Sorbonne University, Paris, France., Kolijn PM; Laboratory of Medical Immunology, Department of Immunology, Erasmus MC University Medical Center, Rotterdam, the Netherlands., Vlachonikola E; Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece., Stewart JP; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, United Kingdom., Pott C; Department of Hematology, University Hospital Schleswig-Holstein, Kiel, Germany., Hummel M; Institute of Pathology, Charité-Universitätsmedizin, Berlin, Germany., Darzentas N; Department of Hematology, University Hospital Schleswig-Holstein, Kiel, Germany., Langerak AW; Laboratory of Medical Immunology, Department of Immunology, Erasmus MC University Medical Center, Rotterdam, the Netherlands., Fend F; Institute of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany., Groenen PJTA; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands; Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. Electronic address: patricia.groenen@radboudumc.nl.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2023 Oct; Vol. 25 (10), pp. 729-739. Date of Electronic Publication: 2023 Jul 17.
Autor:
Khouja, M., Genuardi, E., Ferrero, S., Alessandria, B., Verhagen, O. J., Homburg, C., van der Velden, V. H., Gameiro, P., Sanz, R. García, Herrera, A. Medina, Fronkova, E., Brüggemann, M., Dreyling, M., Hoster, E., Ladetto, M., Langerak, A. W., Darzentas, N., Pal, K., Stewart, P. J., Gonzalez de Castro, D.
Publikováno v:
Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p181-183, 3p
Autor:
Sclafani F, Hulkki Wilson S, Cunningham D, Gonzalez De Castro D, Kalaitzaki E, Begum R, Wotherspoon A, Capdevila J, Glimelius B, Rosello S, Thomas J, Tait D, Brown G, Oates J, Chau I
Publikováno v:
INTERNATIONAL JOURNAL OF CANCER
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Little information is available on the clinical significance of cancer-related genes such as KRAS, NRAS, BRAF, PIK3CA and TP53 in nonmetastatic rectal cancer. We investigated mutations of these genes in a large prospective series of locally advanced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::1251c405e60def9e7a2f6df9f25d56a7
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=3659
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=3659
Autor:
Milton CI; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK., Selfe J; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK., Aladowicz E; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK., Man SYK; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK., Bernauer C; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK., Missiaglia E; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK., Walters ZS; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK., Gatz SA; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK., Kelsey A; Department of Paediatric Histopathology, Manchester University NHS Foundation Trust, Royal Manchester Children's Hospital, UK., Generali M; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK., Box G; Cancer Pharmacology and Stress Response Team, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Valenti M; Cancer Pharmacology and Stress Response Team, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., de Haven-Brandon A; Cancer Pharmacology and Stress Response Team, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Galiwango D; Drug Metabolism and Pharmacokinetics Team, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Hayes A; Drug Metabolism and Pharmacokinetics Team, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Clarke M; Glioma Team, Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Izquierdo E; Glioma Team, Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Gonzalez De Castro D; Molecular Haematology, Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Raynaud FI; Drug Metabolism and Pharmacokinetics Team, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Kirkin V; Cancer Pharmacology and Stress Response Team, Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., Shipley JM; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK.
Publikováno v:
Molecular oncology [Mol Oncol] 2022 Mar; Vol. 16 (6), pp. 1272-1289. Date of Electronic Publication: 2021 Dec 18.
Autor:
Abdelraouf, Fatma, Sharp, Adam, Maurya, Manisha, Mair, Debbie, Wotherspoon, Andrew, Leary, Alex, Gonzalez de Castro, D., Bhosle, Jaishree, Nassef, Ayatallah, Gaafar, Taghrid, Popat, Sanjay, Yap, Timothy A., O'Brien, Mary
Publikováno v:
Abdelraouf, F, Sharp, A, Maurya, M, Mair, D, Wotherspoon, A, Leary, A, Gonzalez de Castro, D, Bhosle, J, Nassef, A, Gaafar, T, Popat, S, Yap, T A & O'Brien, M 2015, ' Focused molecular analysis of small cell lung cancer: feasibility in routine clinical practice. Feasibility in routine clinical practice ', BMC Research Notes, vol. 8, no. 688, 688 . https://doi.org/10.1186/s13104-015-1675-x, https://doi.org/10.1186/s13104-015-1675-x
Background: There is an urgent need to identify molecular signatures in small cell lung cancer (SCLC) that may select patients who are likely to respond to molecularly targeted therapies. In this study, we investigate the feasibility of undertaking f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2607::02b4065872779babdd603796044fcbb4
https://pure.qub.ac.uk/en/publications/33885afe-3122-4e9e-afa2-38ce51383e8d
https://pure.qub.ac.uk/en/publications/33885afe-3122-4e9e-afa2-38ce51383e8d
Autor:
Gonzalez de Castro, D1, Angulo, B2, Gomez, B1, Mair, D1, Martinez, R2, Suarez-Gauthier, A2, Shieh, F3, Velez, M3, Brophy, V H3, Lawrence, H J3, Lopez-Rios, F2
Publikováno v:
British Journal of Cancer. 7/10/2012, Vol. 107 Issue 2, p345-351. 7p.
Autor:
Pearson A; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Proszek P; The Centre for Molecular Pathology, The Royal Marsden Hospital, Sutton, Surrey, United Kingdom., Pascual J; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Fribbens C; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Shamsher MK; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Kingston B; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., O'Leary B; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Herrera-Abreu MT; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Cutts RJ; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Garcia-Murillas I; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Bye H; The Centre for Molecular Pathology, The Royal Marsden Hospital, Sutton, Surrey, United Kingdom., Walker BA; The Centre for Molecular Pathology, The Royal Marsden Hospital, Sutton, Surrey, United Kingdom., Gonzalez De Castro D; The Centre for Molecular Pathology, The Royal Marsden Hospital, Sutton, Surrey, United Kingdom., Yuan L; The Centre for Molecular Pathology, The Royal Marsden Hospital, Sutton, Surrey, United Kingdom., Jamal S; The Centre for Molecular Pathology, The Royal Marsden Hospital, Sutton, Surrey, United Kingdom., Hubank M; The Centre for Molecular Pathology, The Royal Marsden Hospital, Sutton, Surrey, United Kingdom., Lopez-Knowles E; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, London, United Kingdom., Schuster EF; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, London, United Kingdom., Dowsett M; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital, London, United Kingdom., Osin P; Breast Unit, The Royal Marsden Hospital, London, United Kingdom., Nerurkar A; Breast Unit, The Royal Marsden Hospital, London, United Kingdom., Parton M; Breast Unit, The Royal Marsden Hospital, London, United Kingdom., Okines AFC; Breast Unit, The Royal Marsden Hospital, London, United Kingdom., Johnston SRD; Breast Unit, The Royal Marsden Hospital, London, United Kingdom., Ring A; Breast Unit, The Royal Marsden Hospital, London, United Kingdom., Turner NC; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom. nick.turner@icr.ac.uk.; Breast Unit, The Royal Marsden Hospital, London, United Kingdom.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Feb 01; Vol. 26 (3), pp. 608-622. Date of Electronic Publication: 2019 Oct 07.